Showing 2551-2560 of 4166 results for "".
- OD-OS Releases Intuitive Iridotomy Treatment with the Navilas 577s Retina Laserhttps://modernod.com/news/od-os-releases-intuitive-iridotomy-treatment-with-the-navilas-577s-retina-laser/2479613/OD-OS has released a software update for its Navilas 577s retinal laser system (version 3.5) that incorporates a new intuitive anterior segment treatment mode for Laser Peripheral Iridotomy (LPI). The new LPI treatment mode supports the therapy of narrow-angle glaucoma and thus can contribute to
- Thomas W. Samuelson, MD, Named 2018 ASCRS Presidenthttps://modernod.com/news/thomas-w-samuelson-md-named-2018-ascrs-president/2480251/Thomas W. Samuelson, MD, a world-renowned ophthalmologist who specializes in the medical and surgical treatment of glaucoma and disorders of the anterior segment, will assume his role as president of the American Society of Cataract and Refractive Surgery (ASCRS) in April 2018. He currently serve
- Iantrek Publishes Clinical Results of Uveoscleral Outflow Technology for Open-Angle Glaucomahttps://modernod.com/news/iantrek-publishes-clinical-results-of-uveoscleral-outflow-technology-for-open-angle-glaucoma/2482437/Iantrek announced the publication of clinical results highlighting the efficacy of Iantrek’s uveoscleral outflow technology for the treatment of glaucoma. The results, published in the Journal of Clinical Medici
- PulseSight Therapeutics Establishes International Scientific and Clinical Advisory Boardhttps://modernod.com/news/pulsesight-therapeutics-establishes-international-scientific-and-clinical-advisory-board/2482424/PulseSight Therapeutics announced the formation of a Scientific and Clinical Advisory Board (SAB) composed of internationally recognized experts in ophthalmology from Europe, the US, and Australia with extensive experience in both fundamental and clinical research in retinal and macular
- Nicox Establishes High-Profile Glaucoma Clinical Advisory Boardhttps://modernod.com/news/nicox-establishes-high-profile-glaucoma-clinical-advisory-board/2479601/Nicox SA announced the formation of Nicox Glaucoma Clinical Advisory Board, composed of key clinical investigators and opinion leaders in the field, to support and guide the development of its innovative NO-donating compounds as potential IOP-lowering drugs.
- EyePoint Pharmaceuticals Announces 2022 Clinical Plans and Highlights Recent Corporate and Clinical Achievementshttps://modernod.com/news/eyepoint-pharmaceuticals-announces-2022-clinical-plans-and-highlights-recent-corporate-and-clinical-achievements/2480554/EyePoint Pharmaceuticals announced its 2022 clinical pipeline plans and highlighted recent corporate achievements driven by its lead pipeline candidate, EYP-1901, a potential 6-month intravitreal treatment targeting wet age-related macular degeneration (AMD).
- ViaLase to Present New Clinical Data at ASCRShttps://modernod.com/news/vialase-to-present-new-clinical-data-at-ascrs/2482214/ViaLase announced that it will present clinical data as well as provide a business and technology overview during the 2024 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held April 5-8, 2024 in Boston, Massachusetts. ViaLase will be exhibiting onsite at boot
- Opthea Names New Clinical and Regulatory Leadership Membershttps://modernod.com/news/opthea-names-new-clinical-and-regulatory-leadership-members/2482091/Opthea announced the appointment of Julie Clark, MD, MS, as Senior Vice President (SVP), Clinical Development; and Fang Li, PhD, RAC, as SVP, Regulatory Affairs, effective February 1, 2024. Dr. Clark and Dr. Li will report to Opthea Chief Executive Officer Frederic Guerard, PharmD,
- Heru Surpasses Clinical Milestone of 100,000 Eyes Examinedhttps://modernod.com/news/heru-surpasses-clinical-milestone-of-100000-eyes-examined/2481242/Heru announced that it has passed the clinical milestone of over 100,000 patient eyes that have been examined using its wearable technology since the company’s commercial launch a little over a year ago. “We are thrilled to see the rapid adoption of the Heru platform,&r
- Ocular Therapeutix To Present Clinical Data at ASCRShttps://modernod.com/news/ocular-therapeutix-to-present-clinical-data-at-ascrs/2479403/Ocular Therapeutix announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting being held July 23-27, 2021 in Las Vegas. “At ASCRS, we will be presenting data on multiple programs we are advancing in the clinic as well